Reaction Details Report a problem with these data
Target
Alpha-synuclein
Ligand
BDBM207895
Substrate
n/a
Meas. Tech.
In Vitro Inhibition Assay
EC50
20±n/a nM
Citation
 Griffioen, G; Van Dooren, T; Rojas De La Parra, V; Allasia, S; Marchand, A; Kilonda, A; Chaltin, P Compounds for the treatment of neurodegenerative diseases US Patent  US9266832 Publication Date 2/23/2016 
Target
Name:
Alpha-synuclein
Synonyms:
NACP | PARK1 | SNCA | SYUA_HUMAN
Type:
Protein
Mol. Mass.:
14451.42
Organism:
Homo sapiens (Human)
Description:
P37840
Residue:
140
Sequence:
MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA
  
Inhibitor
Name:
BDBM207895
Synonyms:
US9266832, Cpd052
Type:
Small organic molecule
Emp. Form.:
C24H20ClFN2O
Mol. Mass.:
406.88
SMILES:
Fc1ccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)cc1
Structure:
Search PDB for entries with ligand similarity: